Kolawole Olayinka Oyelese, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vasa Previa | 12 | 2023 | 28 | 7.890 |
Why?
|
Ultrasonography, Prenatal | 31 | 2023 | 1695 | 4.190 |
Why?
|
Umbilical Cord | 13 | 2021 | 180 | 3.030 |
Why?
|
Abruptio Placentae | 8 | 2014 | 118 | 1.470 |
Why?
|
Prenatal Diagnosis | 10 | 2023 | 1237 | 1.350 |
Why?
|
Pregnancy | 74 | 2023 | 29140 | 1.340 |
Why?
|
Pregnancy, High-Risk | 5 | 2020 | 120 | 1.280 |
Why?
|
Obstetrics | 4 | 2023 | 657 | 1.190 |
Why?
|
Obstetric Labor, Premature | 5 | 2018 | 278 | 1.160 |
Why?
|
Pregnancy Outcome | 14 | 2020 | 2794 | 1.150 |
Why?
|
Cerclage, Cervical | 3 | 2018 | 39 | 1.140 |
Why?
|
Placenta Previa | 5 | 2009 | 117 | 1.010 |
Why?
|
Cesarean Section | 15 | 2023 | 1365 | 0.870 |
Why?
|
Pregnancy Complications | 10 | 2020 | 2861 | 0.740 |
Why?
|
Delivery, Obstetric | 6 | 2020 | 906 | 0.740 |
Why?
|
Breech Presentation | 1 | 2020 | 44 | 0.720 |
Why?
|
Postpartum Hemorrhage | 3 | 2010 | 258 | 0.720 |
Why?
|
Placenta | 8 | 2021 | 1699 | 0.710 |
Why?
|
Premature Birth | 5 | 2023 | 1722 | 0.700 |
Why?
|
Placenta Diseases | 5 | 2012 | 199 | 0.690 |
Why?
|
Amniotic Fluid | 3 | 2012 | 370 | 0.680 |
Why?
|
Stillbirth | 5 | 2023 | 346 | 0.670 |
Why?
|
Labor Presentation | 3 | 2004 | 53 | 0.650 |
Why?
|
Uterine Cervical Incompetence | 1 | 2018 | 29 | 0.630 |
Why?
|
Gynecology | 2 | 2023 | 512 | 0.620 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2010 | 245 | 0.610 |
Why?
|
Uterine Rupture | 3 | 2003 | 72 | 0.610 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 489 | 0.610 |
Why?
|
Urogenital Abnormalities | 1 | 2020 | 261 | 0.590 |
Why?
|
Trisomy | 2 | 2010 | 265 | 0.580 |
Why?
|
Dehydration | 1 | 2018 | 232 | 0.570 |
Why?
|
Gestational Age | 12 | 2022 | 3488 | 0.560 |
Why?
|
Uterus | 2 | 2020 | 711 | 0.550 |
Why?
|
Fetal Diseases | 3 | 2014 | 903 | 0.550 |
Why?
|
Labor, Obstetric | 2 | 2020 | 333 | 0.530 |
Why?
|
Cervical Length Measurement | 1 | 2015 | 41 | 0.510 |
Why?
|
Fetomaternal Transfusion | 1 | 2014 | 11 | 0.500 |
Why?
|
Pregnancy Trimester, Second | 5 | 2010 | 732 | 0.470 |
Why?
|
Perinatal Mortality | 1 | 2014 | 105 | 0.470 |
Why?
|
Pre-Eclampsia | 3 | 2018 | 1200 | 0.450 |
Why?
|
Female | 78 | 2023 | 380020 | 0.440 |
Why?
|
Cervix Uteri | 6 | 2018 | 590 | 0.440 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2020 | 2027 | 0.430 |
Why?
|
Creatinine | 1 | 2018 | 1918 | 0.430 |
Why?
|
Fetal Monitoring | 2 | 2011 | 70 | 0.430 |
Why?
|
Tocolytic Agents | 2 | 2003 | 24 | 0.410 |
Why?
|
Fetus | 4 | 2022 | 1880 | 0.400 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1199 | 0.400 |
Why?
|
Parturition | 1 | 2015 | 441 | 0.390 |
Why?
|
Peer Review, Research | 1 | 2014 | 329 | 0.390 |
Why?
|
Directive Counseling | 1 | 2012 | 166 | 0.380 |
Why?
|
Oligohydramnios | 3 | 2012 | 35 | 0.360 |
Why?
|
Ultrasonography, Doppler, Color | 5 | 2006 | 233 | 0.360 |
Why?
|
Umbilical Arteries | 3 | 2012 | 75 | 0.360 |
Why?
|
Oxytocics | 3 | 2011 | 68 | 0.360 |
Why?
|
Obstetric Labor Complications | 3 | 2008 | 238 | 0.350 |
Why?
|
Editorial Policies | 1 | 2014 | 451 | 0.340 |
Why?
|
Infant, Newborn | 19 | 2023 | 25609 | 0.340 |
Why?
|
Humans | 80 | 2023 | 743811 | 0.300 |
Why?
|
New Jersey | 5 | 2020 | 290 | 0.300 |
Why?
|
Publishing | 1 | 2014 | 833 | 0.290 |
Why?
|
Hemostatic Techniques | 1 | 2007 | 116 | 0.280 |
Why?
|
Meconium | 1 | 2006 | 48 | 0.280 |
Why?
|
Adult | 45 | 2021 | 213889 | 0.270 |
Why?
|
Hysterectomy | 3 | 2008 | 927 | 0.270 |
Why?
|
Amniocentesis | 1 | 2005 | 116 | 0.270 |
Why?
|
Infant Mortality | 3 | 2005 | 755 | 0.260 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3134 | 0.260 |
Why?
|
Erythrocytes | 1 | 2014 | 2455 | 0.250 |
Why?
|
Terbutaline | 1 | 2003 | 23 | 0.230 |
Why?
|
Twins | 1 | 2005 | 339 | 0.230 |
Why?
|
Hypertension | 1 | 2023 | 8480 | 0.220 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2023 | 254 | 0.220 |
Why?
|
Periodicals as Topic | 1 | 2014 | 1429 | 0.220 |
Why?
|
Proteins | 1 | 2018 | 6098 | 0.220 |
Why?
|
Placenta Accreta | 1 | 2006 | 225 | 0.210 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2014 | 500 | 0.210 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2278 | 0.210 |
Why?
|
Pregnancy, Ectopic | 1 | 2003 | 141 | 0.210 |
Why?
|
Ovarian Cysts | 1 | 2002 | 115 | 0.210 |
Why?
|
Ritodrine | 1 | 2000 | 4 | 0.190 |
Why?
|
Patient Discharge | 2 | 2013 | 3317 | 0.190 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3391 | 0.190 |
Why?
|
Retrospective Studies | 18 | 2022 | 77410 | 0.180 |
Why?
|
Misoprostol | 1 | 2001 | 95 | 0.180 |
Why?
|
Umbilical Veins | 1 | 2000 | 433 | 0.180 |
Why?
|
Labor, Induced | 1 | 2001 | 146 | 0.180 |
Why?
|
Fetal Death | 2 | 1998 | 448 | 0.180 |
Why?
|
Pelvic Neoplasms | 1 | 2002 | 254 | 0.180 |
Why?
|
Pregnancy, Multiple | 1 | 2000 | 217 | 0.170 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3229 | 0.170 |
Why?
|
Sampling Studies | 1 | 2020 | 622 | 0.160 |
Why?
|
Communication | 1 | 2012 | 3748 | 0.160 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 738 | 0.160 |
Why?
|
Prenatal Care | 1 | 2005 | 1092 | 0.150 |
Why?
|
Nitroglycerin | 1 | 1998 | 325 | 0.150 |
Why?
|
Risk | 2 | 2023 | 9677 | 0.140 |
Why?
|
Ultrasonography, Doppler | 3 | 2005 | 458 | 0.140 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12954 | 0.140 |
Why?
|
Leiomyoma | 1 | 2002 | 730 | 0.140 |
Why?
|
Risk Factors | 16 | 2017 | 72252 | 0.140 |
Why?
|
Outpatients | 1 | 2023 | 1488 | 0.130 |
Why?
|
New England | 1 | 2018 | 1022 | 0.130 |
Why?
|
Appendicitis | 1 | 2002 | 645 | 0.130 |
Why?
|
Proteinuria | 1 | 2018 | 658 | 0.130 |
Why?
|
Tocolysis | 2 | 2006 | 18 | 0.130 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2007 | 140 | 0.130 |
Why?
|
Fetal Growth Retardation | 1 | 1998 | 566 | 0.120 |
Why?
|
Blood Vessels | 1 | 2000 | 1124 | 0.120 |
Why?
|
Maternal Mortality | 1 | 2017 | 310 | 0.120 |
Why?
|
Nitric Oxide | 1 | 2023 | 2132 | 0.120 |
Why?
|
Australia | 1 | 2017 | 1167 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 1998 | 974 | 0.120 |
Why?
|
Postmenopause | 1 | 2002 | 2458 | 0.120 |
Why?
|
Incidence | 7 | 2023 | 20948 | 0.110 |
Why?
|
Progesterone | 1 | 2018 | 773 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2014 | 588 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
Fertilization in Vitro | 1 | 2000 | 1283 | 0.110 |
Why?
|
Nuchal Cord | 1 | 2012 | 5 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.110 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3794 | 0.110 |
Why?
|
Triplets | 2 | 2003 | 43 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 9944 | 0.100 |
Why?
|
Paternal Age | 1 | 2012 | 84 | 0.100 |
Why?
|
Polyhydramnios | 1 | 2012 | 41 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2000 | 1161 | 0.100 |
Why?
|
Parity | 4 | 2013 | 929 | 0.100 |
Why?
|
Health Facilities | 1 | 2017 | 572 | 0.100 |
Why?
|
Postpartum Period | 1 | 2018 | 1086 | 0.100 |
Why?
|
Fetal Movement | 1 | 2011 | 21 | 0.100 |
Why?
|
Gravidity | 2 | 2008 | 51 | 0.100 |
Why?
|
Fetal Distress | 1 | 2011 | 40 | 0.100 |
Why?
|
Liability, Legal | 1 | 2012 | 213 | 0.100 |
Why?
|
Heart Rate, Fetal | 1 | 2011 | 75 | 0.090 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2568 | 0.090 |
Why?
|
Uterine Contraction | 1 | 2011 | 93 | 0.090 |
Why?
|
Biophysical Phenomena | 1 | 2011 | 327 | 0.090 |
Why?
|
Consumer Health Information | 1 | 2012 | 211 | 0.090 |
Why?
|
Cohort Studies | 9 | 2020 | 40545 | 0.090 |
Why?
|
Congenital Abnormalities | 2 | 2013 | 707 | 0.080 |
Why?
|
Patient Admission | 2 | 2014 | 1380 | 0.080 |
Why?
|
Uterine Hemorrhage | 2 | 2008 | 255 | 0.080 |
Why?
|
Recurrence | 4 | 2010 | 8337 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2010 | 980 | 0.080 |
Why?
|
Blood Pressure | 1 | 2023 | 8551 | 0.080 |
Why?
|
Risk Assessment | 6 | 2020 | 23327 | 0.070 |
Why?
|
Oxytocin | 1 | 2011 | 394 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2011 | 35409 | 0.070 |
Why?
|
Aspirin | 1 | 1998 | 3283 | 0.070 |
Why?
|
Natural Childbirth | 1 | 2006 | 18 | 0.070 |
Why?
|
Maternal Age | 4 | 2013 | 802 | 0.070 |
Why?
|
Thymus Gland | 1 | 2011 | 1266 | 0.070 |
Why?
|
Informed Consent | 1 | 2012 | 995 | 0.070 |
Why?
|
Prospective Studies | 4 | 2020 | 53250 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1998 | 3070 | 0.070 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 139 | 0.070 |
Why?
|
Young Adult | 6 | 2014 | 56392 | 0.070 |
Why?
|
Balloon Occlusion | 1 | 2006 | 126 | 0.060 |
Why?
|
Meningocele | 1 | 2005 | 45 | 0.060 |
Why?
|
Prolapse | 1 | 2004 | 68 | 0.060 |
Why?
|
Goiter | 1 | 2005 | 87 | 0.060 |
Why?
|
Hernia, Umbilical | 1 | 2005 | 96 | 0.060 |
Why?
|
Down Syndrome | 1 | 2013 | 880 | 0.060 |
Why?
|
Arteriovenous Malformations | 1 | 2007 | 396 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2003 | 5033 | 0.060 |
Why?
|
Respiration Disorders | 1 | 2007 | 371 | 0.060 |
Why?
|
Thrombophilia | 1 | 2006 | 305 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15067 | 0.060 |
Why?
|
Exercise Test | 1 | 2011 | 2074 | 0.060 |
Why?
|
Sacrum | 1 | 2005 | 288 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.060 |
Why?
|
Pregnancy Trimester, Third | 2 | 2004 | 571 | 0.060 |
Why?
|
Patient Participation | 1 | 2012 | 1457 | 0.060 |
Why?
|
Thromboembolism | 1 | 2009 | 987 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2004 | 520 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19894 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2715 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1256 | 0.050 |
Why?
|
Unnecessary Procedures | 1 | 2005 | 432 | 0.050 |
Why?
|
Injections, Subcutaneous | 1 | 2003 | 667 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2006 | 2556 | 0.050 |
Why?
|
Rupture, Spontaneous | 1 | 2002 | 354 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7658 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14714 | 0.050 |
Why?
|
Infant | 1 | 2022 | 35122 | 0.050 |
Why?
|
CA-125 Antigen | 1 | 2002 | 286 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3608 | 0.050 |
Why?
|
Laparotomy | 1 | 2002 | 473 | 0.050 |
Why?
|
Decision Making | 1 | 2014 | 3887 | 0.050 |
Why?
|
Fetal Development | 1 | 2005 | 767 | 0.040 |
Why?
|
Physical Examination | 1 | 2006 | 1235 | 0.040 |
Why?
|
Methotrexate | 1 | 2006 | 1726 | 0.040 |
Why?
|
Morbidity | 1 | 2005 | 1768 | 0.040 |
Why?
|
Placental Circulation | 1 | 1998 | 40 | 0.040 |
Why?
|
Appendectomy | 1 | 2002 | 401 | 0.040 |
Why?
|
Models, Statistical | 1 | 2013 | 5100 | 0.040 |
Why?
|
Placental Insufficiency | 1 | 1998 | 51 | 0.040 |
Why?
|
Age Distribution | 3 | 2012 | 2899 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 5986 | 0.040 |
Why?
|
Weight Gain | 1 | 2007 | 2294 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 552 | 0.040 |
Why?
|
Cerebellum | 1 | 2004 | 1487 | 0.040 |
Why?
|
Infant, Premature | 1 | 2005 | 2031 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2000 | 2274 | 0.030 |
Why?
|
United States | 6 | 2015 | 69859 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 1999 | 1525 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 3912 | 0.030 |
Why?
|
Confidence Intervals | 3 | 2006 | 2971 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2003 | 4931 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2760 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5251 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2005 | 4033 | 0.030 |
Why?
|
Resuscitation | 1 | 1999 | 658 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 778 | 0.030 |
Why?
|
Middle Aged | 5 | 2020 | 213241 | 0.030 |
Why?
|
Hospitals | 1 | 2005 | 3953 | 0.020 |
Why?
|
Male | 8 | 2020 | 349776 | 0.020 |
Why?
|
Laparoscopy | 1 | 2002 | 2148 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12243 | 0.020 |
Why?
|
Probability | 2 | 2006 | 2505 | 0.020 |
Why?
|
Body Mass Index | 1 | 2007 | 12718 | 0.020 |
Why?
|
Prevalence | 2 | 2006 | 15211 | 0.020 |
Why?
|
Hospitalization | 1 | 2009 | 10259 | 0.020 |
Why?
|
Prognosis | 2 | 2013 | 29052 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2003 | 3921 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 1998 | 6487 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15526 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2005 | 5136 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2006 | 39001 | 0.020 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2008 | 188 | 0.020 |
Why?
|
Ligation | 1 | 2008 | 452 | 0.020 |
Why?
|
Health Care Surveys | 2 | 2005 | 2453 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2007 | 383 | 0.020 |
Why?
|
Cesarean Section, Repeat | 1 | 2006 | 29 | 0.020 |
Why?
|
Decidua | 1 | 2006 | 86 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
Propylthiouracil | 1 | 2005 | 69 | 0.020 |
Why?
|
Antithyroid Agents | 1 | 2005 | 70 | 0.020 |
Why?
|
Observer Variation | 1 | 2011 | 2592 | 0.020 |
Why?
|
Pneumonia, Bacterial | 1 | 2007 | 316 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2007 | 600 | 0.010 |
Why?
|
District of Columbia | 1 | 2003 | 157 | 0.010 |
Why?
|
Mathematics | 1 | 2004 | 727 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 2008 | 565 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 40038 | 0.010 |
Why?
|
Arteries | 1 | 2008 | 1119 | 0.010 |
Why?
|
Hyperthyroidism | 1 | 2005 | 295 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 2005 | 456 | 0.010 |
Why?
|
Chronic Disease | 2 | 2007 | 9139 | 0.010 |
Why?
|
Thyroxine | 1 | 2005 | 667 | 0.010 |
Why?
|
Registries | 2 | 2007 | 8090 | 0.010 |
Why?
|
Adolescent | 4 | 2013 | 85729 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2006 | 63042 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2009 | 21733 | 0.010 |
Why?
|
Family | 1 | 2009 | 3144 | 0.010 |
Why?
|
Reoperation | 1 | 2008 | 4200 | 0.010 |
Why?
|
Thyroid Gland | 1 | 2005 | 1173 | 0.010 |
Why?
|
Medical Records | 1 | 2003 | 1412 | 0.010 |
Why?
|
Acute Disease | 1 | 2007 | 7150 | 0.010 |
Why?
|
Overweight | 1 | 2007 | 2371 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 5983 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2008 | 3679 | 0.010 |
Why?
|
Logistic Models | 1 | 2005 | 13404 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2006 | 13980 | 0.010 |
Why?
|
Inflammation | 1 | 2006 | 10629 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2008 | 15281 | 0.000 |
Why?
|
Obesity | 1 | 2007 | 12744 | 0.000 |
Why?
|